옵션 체인은 다양한 행사가격과 만기일에 대한 Ionis Pharmaceuticals의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Ionis Pharmaceuticals에 대한 시장 심리를 평가합니다..

Ionis Pharmaceuticals (NASDAQ:IONS) 주식, 옵션 체인

Ionis Pharmaceuticals

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024.

Broad U.S. Equity ETFs

Education

Specialty ETFs

Tech

ETFs

ADPT

ARKG

ARKK

CDNA

COIN

CRSP

HOOD

IONS

NRIX

NTRA

PATH

PLTR

RBLX

ROKU

RXRX

SHOP

TSLA

TWST

VYCT

캐시 우드가 이끄는 아크 펀드(Ark Funds)는 미래 성장 혁신 분야에 중점을 두고 적극적으로 관리되는 ETF들 덕분에 가장 잘 알려진 펀드 매니저 중 하나이다. 이 펀드의 ETF 두 개가 목요일에 10주년을 맞이했다. 이들 펀드의 출시와 지난 10년 동안의 성과를 살펴보겠다.

캐시 우드의 아크 이노베이션, 지노믹스 ETF가 10주년을 기념: 연간 수익률을 S&amp;P 500과 비교

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals Inc

JP Morgan analyst Jeffrey Zekauskas upgrades Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) from Neutral to Overweight and lowers the price target from $210 to $205.

News

Upgrades

Price Target

Analyst Ratings

JP Morgan Upgrades Avery Dennison to Overweight, Lowers Price Target to $205

Baird analyst Benjamin Hartford downgrades United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) from Outperform to Neutral and lowers the price target from $160 to $130.

Downgrades

Baird Downgrades United Parcel Service to Neutral, Lowers Price Target to $130

The Company posted KRW 75.8 trillion in consolidated revenue and KRW 6.5 trillion in operating profit in the quarter ended December 31, 2024. For the full year, it reported KRW 300.9 trillion in annual revenue and KRW 32.7 trillion in operating profit.
 &nbsp;

Earnings

Guidance

SSNLF

Reported Earlier, Samsung Electronics Says Q1 Overall Earnings Improvement May Be Limited Due To Weakness In Semiconductors Business

Jefferies analyst Christopher LeFemina initiates coverage on Core Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>) with a Hold rating and announces Price Target of $93.

Initiation

Jefferies Initiates Coverage On Core Natural Resources with Hold Rating, Announces Price Target of $93

Canaccord Genuity analyst Sumant Kulkarni downgrades Intra-Cellular Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) from Buy to Hold and raises the price target from $119 to $132.

ITCI

Canaccord Genuity Downgrades Intra-Cellular Therapies to Hold, Raises Price Target to $132

Global payment technology companies, Mastercard Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) and Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), which process credit card payments and other financial transactions reported better-than-expected quarterly earnings on Thursday. Shall investors buy, sell or hold these companies? Here&#8217;s what technical analysis suggests.
<h3 class="wp-block-heading">Technical Analysis Of Visa And Mastercard</h3>
Technical analysis suggests both Visa and Mastercard stocks are currently overbought, indicating a potential correction may be imminent, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. 
Visa shares closed Thursday at $343.05, significantly above its eight-day simple moving average of $331.69, 20-day average at $320.65, also 50 and 200-day averages of $316.42, and $285.73, respectively. The relative strength index of 80.35 further reinforces this overbought condition, suggesting recent rapid price increases may be unsustainable.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-1024x576.png" alt="" class="wp-image-759794" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/news/earnings/25/01/43355517/visa-shares-rise-on-solid-q1-results-details">Visa Shares Rise On Solid Q1 Results: Details</a> 
Mastercard shares, on the other hand, also exhibited a similar trend, closing Thursday at $566.01. This price is well above its eight-day average of $541.60, and 20-day average of $526.54. Also, 50 and 200-day averages of $526.67 and $484.31, respectively. With an RSI of 76.67, Mastercard&#8217;s stock is also considered overbought, signaling potential exhaustion of upward momentum and a possible sell signal.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-1024x576.png" alt="" class="wp-image-759795" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/news/earnings/25/01/43345282/mastercard-q4-earnings-revenue-and-eps-beat-strong-growth-in-payments-and-cross-border-transactions">Mastercard Q4 Earnings: Revenue And EPS Beat, Strong Growth In Payments and Cross-Border Transactions</a>
<h3 class="wp-block-heading">Analyst Recommendations</h3>
Despite the warning signs from the technical analysis of daily moving averages, ratings based on analysts tracked by Benzinga have a consensus &#8216;buy&#8217; on both stocks.
Visa also enjoys a consensus &#8220;buy&#8221; rating. The average price target among <a href="https://www.benzinga.com/quote/V/analyst-ratings">34 analysts</a> is $324.06, with a range of $252 to $375. Recent ratings from Piper Sandler, BofA Securities, and Citigroup suggest a $351 target, implying a 0.90% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/V/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="379" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-1024x379.png" alt="" class="wp-image-759801" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-1024x379.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-768x284.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1.png 1062w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/25/01/43376448/elon-musks-x-money-to-see-about-600-million-active-monthly-users-via-visa-direct-integration">Elon Musk&#8217;s &#8216;X Money&#8217; To See About 600 Million Active Monthly Users Via Visa Direct Integration: &#8216;Excited To Partner,&#8217; Says CEO</a>
For Mastercard, the average price target among <a href="https://www.benzinga.com/quote/MA/analyst-ratings">34 analysts</a> is $542.84, with estimates ranging from $424 to $654. Recent ratings from Piper Sandler, Citigroup, and Oppenheimer suggest a $587.67 target, implying a potential upside of 3.53%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/MA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="386" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-1024x386.png" alt="" class="wp-image-759797" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-1024x386.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-768x290.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Price Action: Shares of Visa were up 1.41% and Mastercard advanced 0.29% in premarket on Friday. Whereas the exchange-traded fund tracking S&amp;P 500, SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.49% at $608.01.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/43377987/after-imposing-tariffs-on-canada-donald-trump-threatens-100-levy-on-brics-for-move-against-dollar-how-will-us-manage-production-from-slippers-to-ships-asks-expert">After Imposing Tariffs On Canada, Donald Trump Threatens 100% Levy On BRICS For Move Against Dollar: &#8216;How Will US Manage Production From Slippers To Ships?,&#8217; Asks Expert</a></li>
</ul>
Image Via Shutterstock

Analyst Color

Equities

Market Summary

Futures

Technicals

Markets

Trading Ideas

General

Mastercard Vs. Visa: Buy, Sell Or Hold? Here's What Technical Analysis Suggest

Qudian Announced Appointment Of Marcum Asia CPAs As Company's New Independent Registered Public Accounting Firm

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the &#8220;Neutral&#8221; zone on Thursday.
U.S. stocks settled higher on Thursday, with the Dow Jones index gaining more than 150 points as investors assessed the recent earnings reports from mega-cap tech stocks.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) reported weaker-than-expected fourth-quarter earnings and sales results. The company, meanwhile, said it expects its vehicle business to return to growth in 2025. Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) reported better-than-expected fourth-quarter sales results on Wednesday. Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) reported its second-quarter GAAP earnings of $3.23 per share, beating the $3.11 consensus estimate.
President Donald Trump confirmed Thursday the United States will impose 25% tariffs on imports from Canada and Mexico starting Saturday, Feb. 1.
On the economic data front, U.S. initial jobless claims fell by 16,000 from the previous week to 207,000 in the week ending January 25, compared to market estimates of 220,000. The U.S. economy expanded at an annualized rate of 2.3% in the fourth quarter, down from 3.1% in the previous quarter and versus market estimates of 2.6%.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, real estate and health care stocks recording gains on Thursday. However, information technology stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 169 points to 44,882.13 on Thursday. The S&amp;P 500 rose 0.53% to 6,071.17, while the Nasdaq Composite rose 0.25% at 19,681.75 during Thursday's session.
Investors are awaiting earnings results from Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) and Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) today.
At a current reading of 48.1, the index remained in the &#8220;Neutral&#8221; zone on Thursday, versus a prior reading of 46.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43336168/jim-cramer-likes-this-tech-stock-terrific-business-niche-business">Jim Cramer Likes This Tech Stock: &#8216;Terrific Business, Niche Business&#8217;</a></li>
</ul>

Pre-Market Outlook

MSFT

Dow Jumps Over 150 Points As Investors Monitor Earnings Reports; Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone

Shares of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) rose sharply in today's pre-market trading after the company reported <a href="https://in.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever">better-than-expected first-quarter results.</a>
Apple reported fiscal first-quarter revenue of $124.3 billion, beating analyst estimates of $124.13 billion. The iPhone maker reported first-quarter adjusted earnings of $2.40 per share, beating analyst estimates of $2.36 per share.
Apple shares gained 3.4% to $245.73 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Trident Digital Tech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) gained 104% to $1.94 in pre-market trading after dipping 62% on Thursday.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) rose 63.4% to $2.55 in pre-market trading after announcing a partnership to advance subsea autonomy solutions.</li>
<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) gained 40% to $49.01 in pre-market trading after dipping 30% on Thursday.</li>
<li>Orangekloud Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) gained 37.2% to $1.88 in pre-market trading. Maxim Group analyst Allen Klee initiated coverage on Orangekloud Technology with a Buy rating and announced a price target of $5.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) rose 25.1% to $3.18 in pre-market trading after gaining 7% on Thursday.</li>
<li>Envirotech Vehicles, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVTV#NASDAQ">EVTV</a>) shares jumped 17.7% to $0.4077 in pre-market trading after dipping 48% on Thursday. Envirotech Vehicles recently announced it has received orders for 48 vehicles to New Jersey.</li>
<li>Cipher Mining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) gained 20.9% to $5.68 in pre-market trading after the company announced a $50 million investment from Softbank.</li>
<li>Atlassian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) rose 18.9% to $317.40 in pre-market trading after the company reported better-than-expected second-quarter financial results.</li>
<li>Kimball Electronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KE#NASDAQ">KE</a>) gained 11% to $20.11 in pre-market trading. Kimball Electronics will report second quarter fiscal year 2025 financial results on Tuesday, Feb. 4, 2025, after the closing bell.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Aviat Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) shares fell 46.5% to $10.00 in pre-market trading. Aviat Networks will release its second quarter fiscal 2025 financial results for the period ended Dec. 27, 2024, on Feb. 4, 2025, after the closing bell.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) dipped 39.7% to $2.35 in pre-market trading after the company priced $5 million public offering of 1.67 million common stock &amp; warrants at $3.00/share.</li>
<li>Stabilis Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNG#NASDAQ">SLNG</a>) shares fell 19.7% to $6.00 in pre-market trading.</li>
<li>Klotho Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) fell 19.1% to $0.3202 in today's pre-market trading.</li>
<li>Benson Hill, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NASDAQ">BHIL</a>) shares dipped 18.7% to $3.21 in pre-market trading. Benson Hill shares jumped 119% on Thursday after the company announced results from a controlled broiler feeding trial conducted with Tyson Foods.</li>
<li>American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) shares tumbled 17.8% to $8.01 in pre-market trading.</li>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) fell 15.1% to $189.32 in pre-market trading after the company reported third-quarter results.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) fell 10.4% to $10.28 in pre-market trading after the company suspended its quarterly dividend.</li>
<li>Beazer Homes USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) declined 8.6% to $25.33 in pre-market trading following worse-than-expected reported first-quarter financial results.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) fell 8.4% to $29.44 in pre-market trading following fourth-quarter earnings results.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/25/01/43335398/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields"> Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

Movers

AAPL

AVNW

BHIL

CIFR

CYCN

DECK

DGNX

ENVB

EVTV

KITT

KLTO

ORKT

SLNG

TDTH

TEAM

Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

On Thursday, Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) launched its RTX 5090 and 5080 graphics cards, only to see them sell out almost immediately.
What Happened: The highly anticipated Nvidia Series 5000 GPUs sold out rapidly, leaving many gamers frustrated, <a href="https://in.ign.com/nvidia-rtx-5080/223698/news/nvidia-rtx-5090-and-5080-sell-out-instantly-and-scalpers-are-already-cashing-in-with-6000-ebay-listi">reported</a> IGN. The GPUs were anticipated to have limited availability, a fact Nvidia had previously warned about.
Despite the warning, eager buyers lined up at <a href="https://www.benzinga.com/tech/25/01/43242360/jensen-huang-mania-mirrors-taylor-swift-people-are-camping-outside-retailers-for-nvidia-5000-series-gpus">U.S. distributor Micro Center</a>, hoping to secure one of the coveted cards.
However, the limited stock led to scalpers listing the RTX 5090 on eBay for over $6,000, a significant markup from its $1,999 MSRP, the report noted.
See Also: <a href="https://www.benzinga.com/markets/25/01/43377131/tim-cook-wont-say-how-apple-plans-to-handle-trumps-tariff-policies-but-heres-whats-at-stake-for-the-iphone-maker">Tim Cook Won&#8217;t Say How Apple Plans To Handle Trump&#8217;s Tariff Policies — But Here&#8217;s What&#8217;s At Stake For The iPhone Maker</a>
Third-party manufacturers also increased prices, with the Asus ROG Astral model reaching $2,799.
As a result, gamers expressed their frustration online, with some calling it a &#8220;paper launch&#8221; due to the lack of available stock.
Why It Matters: The scarcity of these GPUs is partly due to a design flaw in Nvidia&#8217;s Blackwell-based processors. This flaw affected production yields, impacting the availability of the RTX 5090 and 5080.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Nvidia&#8217;s focus on data center chips, which share the same manufacturing process, further strained consumer GPU production, the report stated.
Nvidia is expected to report its fourth-quarter earnings on Feb. 26. Last quarter, it posted a <a href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam">revenue of $35.1 billion</a>, marking a 94% year-over-year surge and surpassing Wall Street's consensus estimate of $33.12 billion.
Price Action: Nvidia&#8217;s stock dipped 1.16% in pre-market trading to $123.20 on Friday after closing at $124.65 up 0.77% during regular hours on Thursday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43221770/apples-ipad-turns-15-today-heres-a-throwback-to-when-steve-jobs-explained-called-it-the-third-category-after-phones-and-notebooks" target="_blank" rel="noreferrer noopener">Apple's iPad Turns 15 Today: Here's A Throwback To When Steve Jobs Explained Called It The ‘Third Category' After Phones And Notebooks</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Media

NVDA

Nvidia RTX 5090 And 5080 Sell Out Instantly — Scalpers Jack Up Prices To $6,000 As Gamers Face 'Paper Launch' Frustration

Macro Economic Events

Econ #s

Economics

Germany Unemployment Rate For January 6.2% Vs. 6.2% Est.; 6.1% Prior

Germany Unemployment Change For January 11K Vs. 14K Est.; 10K Prior

Stifel analyst J. Bruce Chan upgrades C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) from Hold to Buy and maintains the price target from $113 to $113.

CHRW

Stifel Upgrades C.H. Robinson Worldwide to Buy, Maintains Price Target to $113

Former Department of Government Efficiency (DOGE) co-leader Vivek Ramaswamy has clarified his departure from the organization, emphasizing a strategic pivot toward elected office while <a href="https://www.benzinga.com/news/25/01/43078027/vivek-ramaswamy-expected-to-exit-trumps-doge-task-force-amid-ohio-governor-bid-report">addressing speculation about his relationship</a> with Tesla Inc. CEO Elon Musk.
What Happened: Speaking on the Flagrant podcast, Ramaswamy detailed his evolving approach to government reform. &#8220;If you want to save a lot of money, you got to do it through legislation,&#8221; Ramaswamy said, highlighting his focus on legal and constitutional issues.
The entrepreneur-turned-politician defended his exit, which had sparked rumors of tension with Musk, by explaining the natural divergence in their approaches. While Musk continues to lead DOGE&#8217;s technology-centric strategy, Ramaswamy expressed his intention to pursue reform through elected office, particularly at the state level.
During the interview, Ramaswamy criticized the current regulatory landscape, pointing to unelected bureaucrats&#8217; outsized influence on policy. &#8220;Most of the laws that decide what you can and can&#8217;t do in your life were actually never passed by Congress,&#8221; he noted, citing examples ranging from fishing licenses to nuclear plant permissions.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Vivek: Kicked out of DOGE? Elon Beef? Trump Relationship and More" width="500" height="281" src="https://www.youtube.com/embed/6dOfkRLWD7M?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/01/43377987/after-imposing-tariffs-on-canada-donald-trump-threatens-100-levy-on-brics-for-move-against-dollar-how-will-us-manage-production-from-slippers-to-ships-asks-expert">After Imposing Tariffs On Canada, Donald Trump Threatens 100% Levy On BRICS For Move Against Dollar: &#8216;How Will US Manage Production From Slippers To Ships?,&#8217; Asks Expert</a>
Why It Matters: While stopping short of a formal announcement, Ramaswamy indicated his political aspirations would be revealed &#8220;in the next couple of weeks.&#8221; His comments particularly highlighted the governor&#8217;s role in driving executive action, suggesting a potential bid for Ohio&#8217;s governorship.
The transition marks a significant shift for Ramaswamy, who sees state-level executive positions as crucial leverage points for implementing meaningful government reform. His focus appears to be on addressing both federal and state-level regulatory challenges through elected office rather than through organizational reform efforts.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43377455/trumps-tariffs-could-force-us-to-buy-venezuelan-oil-theres-no-other-option-on-the-table-says-canadas-foreign-minister">Trump&#8217;s Tariffs Could Force US To Buy Venezuelan Oil: &#8216;There&#8217;s No Other Option On The Table,&#8217; Says Canada&#8217;s Foreign Minister Melanie Joly</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Social Media

Vivek Ramaswamy Clarifies DOGE Exit Amid Speculation Of Sour Ties To Elon Musk, Shifts Focus To Ohio Governorship Bid: 'You Have to Do It Through Legislation'

NIO Says Has Completed Its Previously Announced Repurchase Right Offer Relating To Its 0.50% Convertible Senior Notes Due 2027

Goldman Sachs analyst Michael Ng maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Buy and lowers the price target from $50 to $44.

CMCSA

Goldman Sachs Maintains Buy on Comcast, Lowers Price Target to $44

EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has marked the option for white interiors as sold out on its launch series of the refreshed <a href="https://www.benzinga.com/tech/25/01/43221344/tesla-model-y-pricing-evolution-cuts-hikes-refreshes-over-two-years">Model Y vehicle</a> in the U.S., even before deliveries have commenced. 
What Happened: Tesla launched the refreshed Model Y in the U.S.<a href="https://www.benzinga.com/tech/25/01/43183608/tesla-launches-refreshed-model-y-in-us-with-25-price-hike-full-self-driving-included"> earlier this month</a>. Deliveries of the launch series of the long-range all-wheel drive variant of the refreshed vehicle, priced at $59,990, are slated to start in March. 
Launch series refers to a limited edition of the vehicle with exclusive badging and more that the company intends to make to celebrate the start of production. 
However, the option for customizing the Launch series vehicle with white interiors is already marked as sold out on Tesla&#8217;s U.S. website. Customers now have only the option to opt for an all-black five-seat interior. 
As for exterior paint options, the company has listed just quicksilver, ultra red, pearl white multi-coat, and stealth grey in the U.S. In China, however, the company has also listed an option for glacier blue exterior paint on the vehicle. 
Why It Matters: Tesla CEO Elon Musk&nbsp;said on Wednesday that all of the company's many factories will start producing the new Model Y vehicle starting in February but will <a href="https://www.benzinga.com/25/01/43328898/elon-musk-warns-teslas-new-model-y-will-result-in-several-weeks-of-lost-production-for-ev-giant-in-q1">lose production in the days of retooling factory.</a>
The CEO also warned that margins will be impacted due to idle capacity and other ramp-related costs. However, these challenges will be overcome once production is ramped, he said.
While in the U.S., the refreshed vehicle is listed alongside older versions of the vehicle, in China, it replaced the older version. In both geographies, deliveries are slated to start in March.
Model Y is manufactured at Tesla's factory in California, as well as its gigafactories in Shanghai, Berlin, and Texas. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43375903/tesla-researcher-estimates-drop-in-ev-deliveries-for-2025-despite-promise-of-new-models">Tesla Researcher Predicts Drop In Deliveries For Elon Musk&#8217;s EV Giant In 2025 Despite New Model Launches</a></li>
<li></li>
</ul>
Image via Tesla

Tesla Marks White Interiors On Launch Series Of Refreshed Model Y As Sold Out Before Deliveries Begin

Piper Sandler analyst Brent Bracelin maintains AppFolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) with a Neutral and maintains $265 price target.

APPF

Piper Sandler Maintains Neutral on AppFolio, Maintains $265 Price Target

BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), the world&#8217;s largest asset management organization, is noted for having a diverse investment portfolio, leveraging trillions of dollars at its disposal to bag shares in companies worldwide. The company has made several successful bets over the years.  
In one of the prime examples, BlackRock increased its exposure to quantum computing stock Rigetti Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) in the third quarter of 2024. Since then, the stock has skyrocketed 1477%.
What happened: According to the 13F filing with the SEC, BlackRock purchased 538,966 shares of RGTI in the third quarter, taking its total holdings to 9,447,600 shares, worth $7.39 million in value then, for the period ending Sept. 30.
This made BlackRock the fifth-biggest shareholder in Rigetti, a firm known for making quantum computers and the superconducting quantum processors that power these computers.
Since then, the company has hit an exponential curve. The stock price has surged 13x, adding billions in market valuation in a few months. RGTI closed at an all-time high of $20 earlier this month.
Assuming BlackRock didn't sell any of the company's shares since reporting its third-quarter investments, its RGTI stash would be worth $116.20 million today.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/01/43325381/elon-musks-tesla-racks-up-600-million-paper-gains-on-bitcoin-in-q4">Elon Musk&#8217;s Tesla Records $600 Million In Paper Gains On Bitcoin In Q4 Thanks To New Accounting Rule</a>&nbsp;
Why It Matters: Rigetti, along with the broader quantum computing space, witnessed tailwinds after tech giant Google teased its next-generation chip, "Willow,&#8221; <a href="https://www.benzinga.com/24/12/42397333/google-quantum-ais-willow-chip-outsmarts-supercomputers-completing-tasks-in-minutes-that-would-take-10-septillion-years">sparking interest</a> in equities tied to the technology.
Defiance Quantum ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTUM#NASDAQ">QTUM</a>), an ETF offering exposure to some of the biggest quantum computing stocks, has gained 32% in the last four months.
Notably, BlackRock has also been known for bullish convictions about Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), the world's largest cryptocurrency. The firm <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42463001/blackrock-advocates-for-2-bitcoin-allocation-in-multi-asset-portfolios">suggested a "reasonable range" for Bitcoin allocation</a> in multi-asset portfolios to be between 1% and 2%.
BlackRock launched its own Bitcoin spot exchange-traded fund last year, called iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), which ended up becoming <a href="https://www.benzinga.com/24/12/42737368/blackrocks-bitcoin-fund-breaks-records-with-historic-etf-launchwill-it-surpass-the-worlds-biggest-gold-etf-in-january">the most successful ETF debut in history</a>.
Price Action: Shares of RGTI were up 0.81% in after-hours trading. The stock closed 2.84% lower at $12.30 during Thursday&#8217;s regular trading session, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43326463/former-senator-bob-menendez-who-said-bitcoin-will-open-doors-of-corruption-in-el-salvador-gets-11-year-jail-term-for-accepting-bribes">Former Senator Bob Menendez Who Said &#8216;Bitcoin Will Open Doors Of Corruption In El Salvador&#8217; Gets 11-Year Jail Term For Accepting Bribes</a></li>
</ul>
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

IBIT

QTUM

RGTI

Bitcoin Backer BlackRock Boosted Exposure To RGTI Stock Right Before Its Jaw-Dropping 1,400% Surge In Quantum Computing Hype

OpenAI CEO Sam Altman announced a technological milestone on Friday, revealing the deployment of NVIDIA Corp.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) first full 8-rack GB200 NVL72 system on Microsoft Corp.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Azure platform, marking a major advancement in the companies&#8217; strategic partnership.
What Happened: &#8220;First full 8-rack GB200 NVL72 now running in Azure for OpenAI—thank you Satya Nadella and Jensen [Huang]!,&#8221; Altman wrote on X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">first full 8-rack GB200 NVL72 now running in azure for openai—thank you <a href="https://twitter.com/satyanadella?ref_src=twsrc%5Etfw">@satyanadella</a> and jensen!
&mdash; Sam Altman (@sama) <a href="https://twitter.com/sama/status/1885191346916356371?ref_src=twsrc%5Etfw">January 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The GB200 NVL72, known for delivering 30 times faster real-time large language model inference and enhanced AI training capabilities, represents the latest evolution in OpenAI&#8217;s infrastructure expansion. This deployment comes as Microsoft reported a 175% year-over-year surge in AI revenue and <a href="https://www.benzinga.com/markets/equities/25/01/43327008/microsofts-13-billion-run-rate-and-openai-azure-deal-spark-surge-in-enterprise-demand-for-ai-solutions-just-first-tranche-of-future-growth-potential">a $13 billion annual AI revenue run rate</a>.
large language model inference is&nbsp;the process by which LLMs use their training to generate human-like responses to user input.
The infrastructure upgrade arrives amid reports that SoftBank Group Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) is in discussions to lead a massive $40 billion <a href="https://www.benzinga.com/media/25/01/43374528/softbank-may-lead-openais-40-billion-funding-round-at-a-300-billion-valuation-despite-deepseek-disruption-report">funding round for OpenAI</a> at a potential $300 billion valuation. 
However, OpenAI faces challenges on the competitive front. The company recently alleged that Chinese AI startup DeepSeek <a href="https://www.benzinga.com/news/25/01/43354099/openai-alleges-deepseek-used-proprietary-models-without-permission-as-microsoft-investigates-ai-secu">used its proprietary models without authorization</a>, leading to the blocking of suspected accounts for terms of service violations. 
See Also: <a href="https://www.benzinga.com/tech/25/01/43377716/tesla-employee-headcount-drops-after-april-layoff">Tesla Reports Over 10% Employee Reduction By Year-End Following April Layoffs</a>
Why It Matters: This controversy emerged after DeepSeek claimed to have developed its R1 model for just $5.6 million using lower-end Nvidia chips.
Microsoft CEO Satya Nadella acknowledged DeepSeek&#8217;s &#8220;real innovations&#8221; during a recent earnings call but remained noncommittal about whether these developments mark a turning point <a href="https://www.benzinga.com/tech/25/01/43327016/microsoft-ceo-satya-nadella-accepts-deepseek-ai-has-some-real-innovations-but-wont-say-if-they-mark-a-turning-point-for-ai-cost-reduction">for AI cost reduction</a>. 
Despite these challenges, OpenAI appears to be strengthening its partnership with Microsoft. Earlier this week, Altman <a href="https://www.benzinga.com/news/25/01/43354099/openai-alleges-deepseek-used-proprietary-models-without-permission-as-microsoft-investigates-ai-secu">hinted at expanded collaboration</a>, stating on social media that the &#8220;next phase of the MSFT x OAI partnership is gonna be much better than anyone is ready for.&#8221; 
This aligns with Microsoft CFO Amy Hood&#8216;s recent statement that OpenAI&#8217;s Azure commitment represents just the &#8220;first tranche&#8221; of future growth potential.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43373775/tim-cook-praises-chinas-deepseek-for-driving-efficiency-stresses-apples-prudent-and-deliberate-approach-toward-capital-expenditure">Tim Cook Praises China&#8217;s DeepSeek For Driving Efficiency, Stresses Apple&#8217;s &#8216;Prudent And Deliberate&#8217; Approach Toward Capital Expenditure</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

SFTBY

Sam Altman Thanks Satya Nadella, Jensen Huang As OpenAI Deploys NVIDIA's GB200 On Microsoft Azure, Boosting Performance By 30X

Insider trades: Walmart, Teva among notable names this week

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ionis Pharmaceuticals (IONS – Research Report) and...

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Anteris Technologies Global Corp. (AVR)

Ionis Pharmaceuticals (IONS) announced highlights from the company's 2024 achievements and previewed important milestones expected in 2025. The hig...

Ionis unveils pipeline plan for 2025, expects 4 independent product launches

Analyst Michael Ulz of Morgan Stanley maintained a Hold rating on Ionis Pharmaceuticals (IONS – Research Report), retaining the price target of $55...

Ionis Pharmaceuticals: Hold Rating Amid Uncertainty in Future Financial Performance

Ionis Pharmaceuticals (IONS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

Ionis Pharmaceuticals: Strategic Path to Cash Flow Positivity and Strong Pipeline Drive Buy Rating

David Lebowitz, an analyst from Citi, maintained the Buy rating on Ionis Pharmaceuticals (IONS – Research Report). The associated price target rema...

Ionis Pharmaceuticals: Promising Pipeline and Strategic Shifts Drive Buy Rating

RBC Capital analyst Luca Issi reiterated a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $70.00. The...

RBC Capital Sticks to Its Buy Rating for Ionis Pharmaceuticals (IONS)

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price ...

Ionis Pharmaceuticals: Strong Pipeline and Market Potential Drive 'Buy' Rating

Biogen wins U.S. EU review for higher dose version of SMA drug marketed with Ionis

Neutral On Metagenomi's Promising Yet Highly Speculative Gene Editing Potential

AZNCF

BIIB

TEVA

Press Releases

Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE

Ionis reports third quarter 2024 financial results

Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome

Ionis to present at upcoming investor conferences

Health Care

Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

Ionis to present at 43rd Annual J.P. Morgan Healthcare Conference

Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities

Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum

Comments

Ionis Pharmaceuticals

Ionis Pharmaceuticals (IONS) 옵션

Ionis Pharmaceuticals (NASDAQ:IONS) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌